These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39055749)

  • 1. Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia.
    Townsend K; Leck C; Billahalli T; Barachina E; Watts TJ
    Allergol Select; 2024; 8():265-269. PubMed ID: 39055749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Süleyman A; Tamay Z; Güler N
    Pediatr Pulmonol; 2022 Nov; 57(11):2622-2628. PubMed ID: 35833362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
    Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin-Tazobactam Hypersensitivity: A Large, Multicenter Analysis.
    Casimir-Brown RS; Kennard L; Kayode OS; Siew LQC; Makris M; Tsilochristou O; Chytiroglou E; Nakonechna A; Rutkowski K; Mirakian R; Wagner A
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2001-2009. PubMed ID: 33444815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte transformation tests predict delayed-type allergy to piperacillin/tazobactam in patients with cystic fibrosis.
    Roehmel JF; Rohrbach A; Staab D; Mall MA; Ogese M; Doerfler F; Naisbitt D
    J Cyst Fibros; 2024 May; 23(3):573-578. PubMed ID: 38087680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model.
    Islam K; Sime FB; Wallis SC; Bauer MJ; Naicker S; Won H; Zowawi HM; Choudhury MA; Shirin T; Habib ZH; Harris PNA; Flora MS; Roberts JA
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0016222. PubMed ID: 35924928
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Karlowsky JA; Lob SH; Siddiqui F; Akrich B; DeRyke CA; Young K; Motyl MR; Hawser SP; Sahm DF
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36763081
    [No Abstract]   [Full Text] [Related]  

  • 9. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Drug Hypersensitivity.
    Pichler WJ; Srinoulprasert Y; Yun J; Hausmann O
    Int Arch Allergy Immunol; 2017; 172(3):129-138. PubMed ID: 28315874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
    LeClaire AC; Martin CA; Hoven AD
    Ann Pharmacother; 2004 Jun; 38(6):996-8. PubMed ID: 15113982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual case of delayed-type hypersensitivity to ceftriaxone and meropenem.
    Dias de Castro E; Leblanc A; Sarmento A; Cernadas JR
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):225-7. PubMed ID: 26549341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U; Böhme C; Rey K; Senn HJ
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
    Micozzi A; Nucci M; Venditti M; Gentile G; Girmenia C; Meloni G; Martino P
    Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):1-8. PubMed ID: 8385015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Cometta A; Zinner S; de Bock R; Calandra T; Gaya H; Klastersky J; Langenaeken J; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):445-52. PubMed ID: 7726513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
    Teitelbaum D; Elligsen M; Katz K; Lam PW; Lo J; MacFadden D; Vermeiren C; Daneman N
    Clin Infect Dis; 2022 Nov; 75(10):1763-1771. PubMed ID: 35380628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.